Pharmaceutical firm Piramal Pharma eyes to double revenue to $ 2 bn by FY30
At the same time, the Ebitda would triple, and the company aims to bring down its net debt to Ebitda levels to 1x by FY30 from the current 2.9x.
At the same time, the Ebitda would triple, and the company aims to bring down its net debt to Ebitda levels to 1x by FY30 from the current 2.9x.
S&P also emphasised the Centre’s focus on fiscal consolidation, as outlined by Finance Minister Nirmala Sitharaman in the July Budget.
The two industry leaders believe the growing interest in equities and SIPs will likely double the investor count to 100 million in the next three to four years.
The agreement aimed to feed the growing energy needs of Microsoft's AI operations while restarting the infamous Pennsylvania facility,
Local retailers have accused quick delivery platforms of anti-competitive practices, a matter the DPIIT has flagged for CCI review, one of the persons quoted above said.
Anil Ambani's Reliance Infrastructure is set to receive Rs 1,100 cr equity infusion from the promoters and another Rs 1,910 crore from two Mumbai-based investment firms
India is on track to becoming the 3rd largest economy by 2030-31, driven by a projected annual growth rate of 6.7% this fiscal, S&P Global said in a report on Thursday.
IREDA share price fell marginally by 0.15 percent on Wednesday, September 18, to end at Rs 227.39. IREDA stock has jumped nearly 120 percent so far this year, since Jan